Modular nanotransporters of anticancer drugs conferring cell specificity and higher efficiency
- PMID: 20210709
- DOI: 10.1134/s0006297909130094
Modular nanotransporters of anticancer drugs conferring cell specificity and higher efficiency
Abstract
This review deals with artificial modular nanotransporters (MNT) of polypeptide nature for drug delivery into target cells and then into a specified cell compartment like the nucleus. The developed approach is based on the use of intracellular transport processes characteristic of practically all cells, including cancer cells. The first MNT module ligand carries out a double function: specific recognition of a cancer target cell and penetration into the cell via receptor-mediated endocytosis. The movement of the MNT within the cell along this path specifies the need to supply the MNT with an endosomolytic module making it possible to leave the endocytotic pathway before getting into lysosomes in order to have time for interaction with importins. For this purpose, a polypeptide fragment able to make defects in membranes only at the pH of endosomes is used as the second module. Delivery into the cell nucleus is provided by the third module containing an amino acid sequence of nuclear localization, "recognized" by importins located in the hyaloplasm. And finally, the fourth module, a carrier for joining the transported drug, is incorporated into the MNT. Depending on the type of ligand module, MNT for different target cell types have been produced. Each module retains its activity within the MNT, ligand modules bind target receptors with high affinity, while the module with the nuclear localization sequence binds importins. The endosomolytic module forms pores in lipid membranes through which MNT are able to leave acidifying cell compartments (endosomes). Modules within MNT can be replaced or transposed, which makes it possible to use them for delivery of different drugs into different target cells and their compartments. It was shown that photosensitizers and radionuclides used for cancer therapy acquire pronounced cell specificity as well as the 10-1000-fold higher efficiency resulting from their delivery into the most vulnerable compartment--the cell nucleus.
Similar articles
-
Development and evaluation of a new modular nanotransporter for drug delivery into nuclei of pathological cells expressing folate receptors.Drug Des Devel Ther. 2017 Apr 26;11:1315-1334. doi: 10.2147/DDDT.S127270. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28490863 Free PMC article.
-
Optimization of a Modular Nanotransporter Design for Targeted Intracellular Delivery of Photosensitizer.Pharmaceutics. 2024 Aug 18;16(8):1083. doi: 10.3390/pharmaceutics16081083. Pharmaceutics. 2024. PMID: 39204428 Free PMC article.
-
[Approaches to the targeted intracellular delivery of photosensitizers in order to enhance their efficacy and cell specificity].Biofizika. 2004 Mar-Apr;49(2):351-79. Biofizika. 2004. PMID: 15129633 Review. Russian.
-
Recombinant modular transporters for cell-specific nuclear delivery of locally acting drugs enhance photosensitizer activity.FASEB J. 2003 Jun;17(9):1121-3. doi: 10.1096/fj.02-0888fje. Epub 2003 Apr 8. FASEB J. 2003. PMID: 12692081
-
Modular Nanotransporters for Nuclear-Targeted Delivery of Auger Electron Emitters.Front Pharmacol. 2018 Aug 27;9:952. doi: 10.3389/fphar.2018.00952. eCollection 2018. Front Pharmacol. 2018. PMID: 30210340 Free PMC article. Review.
Cited by
-
Targeted Intracellular Delivery of Antibodies: The State of the Art.Front Pharmacol. 2018 Oct 24;9:1208. doi: 10.3389/fphar.2018.01208. eCollection 2018. Front Pharmacol. 2018. PMID: 30405420 Free PMC article. Review.
-
Prospects of Using Protein Engineering for Selective Drug Delivery into a Specific Compartment of Target Cells.Pharmaceutics. 2023 Mar 19;15(3):987. doi: 10.3390/pharmaceutics15030987. Pharmaceutics. 2023. PMID: 36986848 Free PMC article. Review.
-
Modular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets.Curr Pharm Des. 2015;21(9):1227-38. doi: 10.2174/1381612820666141013121032. Curr Pharm Des. 2015. PMID: 25312738 Free PMC article. Review.
-
Malignant melanoma and melanocortin 1 receptor.Biochemistry (Mosc). 2013 Nov;78(11):1228-37. doi: 10.1134/S0006297913110035. Biochemistry (Mosc). 2013. PMID: 24460937 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources